Mitigating Thrombus Formation On Medical Devices By Influencing pH Microenvironment Near The Surface
The present disclosure provides treatments of medical devices which inhibit thrombus formation. At least a portion of a substrate of a medical device includes a surface possessing a functionality and/or surface charge adapted to modulate the pH of the surface of the medical device, as well as the pH microenvironment near the surface of a medical device.
1 . A medical device comprising:
at least one substrate possessing a surface; and
a functionality on at least a portion of the surface,
wherein the functionality modulates a pH of a microenvironment near the surface of the medical device.
2 . The medical device of claim 1 , wherein the functionality on at least a portion of the surface is affected by a charged polymer.
3 . The medical device of claim 1 , wherein the medical device is implantable.
4 . The medical device of claim 3 , wherein the medical device is selected from the group consisting of catheters, stents, defibrillators, guidewires, and grafts.
5 . The medical device of claim 1 , wherein the medical device is external to a body of a patient.
6 . The medical device of claim 5 , wherein the medical device is selected from the group consisting of blood transfer devices, dialysis devices, plasmapheresis devices, blood oxygenators, and extracorporeal circuits.
7 . The medical device of claim 1 , wherein the surface of the medical device comprises a lumen of the medical device.
8 . The medical device of claim 1 , wherein the surface of the medical device is a tissue facing surface.
9 . The medical device of claim 1 , wherein the surface of the medical device is a blood contacting surface.
10 . The medical device of claim 1 , wherein the charged polymer comprises a coating on at least a portion of the surface of the medical device.
11 . The medical device of claim 1 , wherein the charged polymer possesses a negative charge.
12 . The medical device of claim 1 , wherein the charged polymer possesses a positive charge.
13 . The medical device of claim 1 , wherein the charged polymer is selected from the group consisting of 2-hydroxyethyl methacrylate, 2-acrylamido-2-methylpropane sulfonic acid, 3-methacryloylaminopropyl-trimethyl ammonium chloride, and combinations thereof.
14 . The medical device of claim 1 , wherein the charged polymer comprises a positively charged copolymer of 3-methacryloylaminopropyl-trimethyl ammonium chloride with 2-hydroxyethyl methacrylate.
15 . The medical device of claim 1 , wherein the charged polymer comprises a negatively charged copolymer of 2-acrylamido-2-methylpropane sulfonic acid with 2-hydroxyethyl methacrylate.
16 . The medical device of claim 1 , wherein the charged polymer is selected from the group consisting of hydroxypropyl methylcellulose, methacrylic acid copolymers, and combinations thereof, in combination with an acid.
17 . The medical device of claim 16 , wherein the charged polymer comprises a copolymer of methacrylic acid with ethyl acrylate.
18 . The medical device of claim 16 , wherein the acid is selected from the group consisting of citric acid, fumaric acid, succinic acid, malic acid, and combinations thereof, present in an amount of from about 0.1 percent by weight to about 10 percent by weight of the copolymer.
19 . A medical device comprising:
at least one substrate possessing a surface; and
a functionality on at least a portion of the surface,
wherein the functionality modulates a pH of a microenvironment near the surface of the medical device to prevent thrombus formation.
20 . The medical device of claim 19 , wherein the functionality on at least a portion of the surface is affected by a charged polymer.